DKK1 and renal fibrosis: It is noteworthy that in an established age‐associated kidney fibrosis model, the administration of DKK1, a specific Wnt inhibitor, and the mitochondrial‐targeted antioxidant mitoQ also protect mitochondrial functions, reduce cellular senescence, and retard renal fibrosis (Figure 6).